Importation of Controlled Substances; Notice of Application, 9677-9678 [05-3800]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 38 / Monday, February 28, 2005 / Notices
Dated: February 15, 2005.
James A. Esget,
Program Manager.
[FR Doc. 05–3751 Filed 2–25–05; 8:45 am]
BILLING CODE 4310–MN–M
DEPARTMENT OF JUSTICE
(CFR), this is notice that on September
28, 2004, Green Acres Farms, Inc.,
Rebecca Marie Yale, 5532 Frances
Avenue, Tacoma, Washington 98422,
made application to the Drug
Enforcement Administration (DEA) for
registration as a bulk manufacturer of
the basic class of controlled substances
listed in Schedule I:
Drug Enforcement Administration
Drug
Schedule
Manufacturer of Controlled
Substances; Notice of Application
Marijuana (7360) ..........................
Tetrahydrocannabinols (7370) .....
Pursuant to 21 CFR 1301.33(a), Title
21 of the Code of Federal Regulations
(CFR), this is notice that on January 13,
2005, Boehringer Ingelheim Chemical
Inc., 2820 N. Normandy Drive,
Petersburg, Virginia 23805, made
application by letter to the Drug
Enforcement Administration (DEA) for
registration as a bulk manufacturer of
Tetrahydrocannabinols (7370), a basic
class of controlled substance listed in
Schedule I.
The company plans to manufacture
the listed controlled substance in bulk
for use in analysis and drug test
standards.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than [60 days from
publication].
The applicant plans to manufacture
(cultivate) Marijuana and
Tetrahydrocannabinols in bulk for
distribution. As documented in the
applicant’s response to the bulk
manufacturer questionnaire submitted
to the Drug Enforcement Administration
(DEA), Green Acres Farms, Inc. stated
its plans ‘‘to support the medical
marijuana market. It is our intention to
manufacture, package and sell to the
various authorized outlets within each
state that has passed a law by its
citizens to allow the medicinal use of
marijuana.’’
Any other such applicant and any
person who is presently registered with
DEA to manufacture such substances
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than (60 days from
publication).
Dated: February 17, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–3798 Filed 2–25–05; 8:45 am]
Dated: February 17, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–3799 Filed 2–25–05; 8:45 am]
BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Importation of Controlled Substances;
Notice of Application
Pursuant to 21 CFR 1301.33(a), Title
21 of the Code of Federal Regulations
Pursuant to 21 U.S.C. 958(1), the
Attorney General shall, prior to issuing
VerDate jul<14>2003
16:34 Feb 25, 2005
Jkt 205001
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
I
I
9677
a registration under this Section to a
bulk manufacturer of a controlled
substance in Schedule I or II and prior
to issuing a regulation under 21 U.S.C.
952 (a)(2)(b) authorizing the importation
of such substances, provide
manufacturers holding registrations for
the bulk manufacture of the substances
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on
November 11, 2004, JFC Technologies,
LLC, 100 West Main Street, PO Box 669,
Bound Brook, New Jersey 08805, made
application by renewal to the Drug
Enforcement Administration (DEA) for
registration as an importer of
Meperidine-Intermediate B (9233), a
basic class of controlled substance listed
in Schedule II.
The company plans to import the
listed controlled substance for the
manufacture of controlled substances in
bulk for distribution to its customers.
Any manufacturer who is presently,
or is applying to be, registered with DEA
to manufacture such basic classes of
controlled substances may file written
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than March 30, 2005.
This procedure is to be conducted
simultaneously with and independent
of the procedures described in 21 CFR
1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import basic class of any
controlled substance in Schedule I or II
are and will continue to be required to
demonstrate to the Deputy Assistant
Administrator, Office of Diversion
Control, Drug Enforcement
Administration that the requirements
for such registration pursuant to 21
U.S.C. 958(a), 21 U.S.C. 823(a), and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
E:\FR\FM\28FEN1.SGM
28FEN1
9678
Federal Register / Vol. 70, No. 38 / Monday, February 28, 2005 / Notices
Dated: February 17, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–3800 Filed 2–25–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Occupational Safety and Health
Administration
[Docket Nos. NRTL2–98, NRTL1–89]
NSF International, Expansion of
Recognition; Application for Renewal
of Recognition; Intertek Testing
Services, NA, Interim Approval Subject
to Review
Occupational Safety and Health
Administration (OSHA), Labor.
ACTION: Notice.
AGENCY:
SUMMARY: This notice announces the
Agency’s final decision on the
application of NSF International (NSF)
for expansion of its recognition as a
Nationally Recognized Testing
Laboratory under 29 CFR 1910.7. This
notice also announces NSF’s
Application for renewal of its
recognition and presents the Agency’s
preliminary finding on the renewal.
This preliminary finding does not
constitute an interim or temporary
approval of the renewal application.
In an unrelated matter, we are adding
one test standard, NFPA 72, Installation,
Maintenance, and Use of Protective
Signaling Systems, to the scope of
recognition of Intertek Testing Services,
NA (ITSNA), on an interim basis,
subject to review.
DATES: Recognition: The expansion of
recognition becomes effective on
February 28, 2005 and, unless modified
in accordance with 29 CFR 1910.7,
continues in effect while NSF remains
recognized by OSHA as an NRTL.
Renewal: Comments on the renewal of
recognition must be received no later
than March 15, 2005. Comments on
Interim Approval: Comments on the
interim approval for test standard NFPA
72 must be received no later than March
15, 2005.
You may submit comments in
response to the renewal application and
the interim approval portions of this
notice, or any request for extension of
the time to comment, by (1) regular
mail, (2) express or overnight delivery
service, (3) hand delivery, (4) messenger
service, or (5) FAX transmission
(facsimile). Because of security-related
problems there may be a significant
VerDate jul<14>2003
16:34 Feb 25, 2005
Jkt 205001
delay in the receipt of comments by
regular mail. Comments (or any request
for extension of the time to comment)
must be submitted by the following
dates:
Regular mail and express delivery
service: Your comments must be
postmarked by March 15, 2005.
Hand delivery and messenger service:
Your comments must be received in the
OSHA Docket Office by March 15, 2005.
OSHA Docket Office and Department of
Labor hours of operation are 8:15 a.m.
to 4:45 p.m.
Facsimile and electronic
transmission: Your comments must be
sent by March 15, 2005.
ADDRESSES: Regular mail, express
delivery, hand-delivery, and messenger
service: You must submit three copies of
your comments and attachments to the
OSHA Docket Office, Docket No.
NRTL2–98 or Docket No. NRTL1–89 (as
applicable), Room N–2625, U.S.
Department of Labor, Occupational
Safety and Health Administration, 200
Constitution Avenue, NW., Washington,
DC 20210. Please contact the OSHA
Docket Office at (202) 693–2350 for
information about security procedures
concerning the delivery of materials by
express delivery, hand delivery and
messenger service.
Facsimile: If your comments,
including any attachments, are 10 pages
or fewer, you may fax them to the OSHA
Docket Office at (202) 693–1648. You
must include the docket number of this
notice, Docket No. NRTL2–98 or Docket
No. NRTL1–89 (as applicable), in your
comments.
Internet access to comments and
submissions: OSHA will place
comments and submissions in response
to this notice on the OSHA Web page
https://www.osha.gov. Accordingly,
OSHA cautions you about submitting
information of a personal nature (e.g.,
social security number, date of birth).
There may be a lag time between when
comments and submissions are received
and when they are placed on the
Webpage. Please contact the OSHA
Docket Office at (202) 693–2350 for
information about materials not
available through the OSHA Webpage
and for assistance in using the Webpage
to locate docket submissions. Comments
and submissions will also be available
for inspection and copying at the OSHA
Docket Office at the address above.
Extension of Comment Period: Submit
requests for extensions concerning this
notice to: Office of Technical Programs
and Coordination Activities, NRTL
Program, Occupational Safety and
Health Administration, U.S. Department
of Labor, Room N3653, 200 Constitution
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
Avenue, NW., Washington, DC 20210.
Or fax to (202) 693–1644.
FOR FURTHER INFORMATION CONTACT:
Bernard Pasquet, Office of Technical
Programs and Coordination Activities,
NRTL Program, Occupational Safety and
Health Administration, U.S. Department
of Labor, 200 Constitution Avenue,
NW., Room N3653, Washington, DC
20210, or phone (202) 693–2110.
SUPPLEMENTARY INFORMATION:
Notice of Final Decision on the
Expansion of Recognition
The Occupational Safety and Health
Administration (OSHA) hereby gives
notice of the expansion of recognition of
NSF International (NSF) as a Nationally
Recognized Testing Laboratory (NRTL).
NSF’s expansion covers the use of an
additional test standard and two
supplemental programs. OSHA’s current
scope of recognition for NSF may be
found in the following informational
Web page: https://www.osha.gov/dts/
otpca/nrtl/nsf.html.
OSHA recognition of an NRTL
signifies that the organization has met
the legal requirements in Section 1910.7
of Title 29, Code of Federal Regulations
(29 CFR 1910.7). Recognition is an
acknowledgment that the organization
can perform independent safety testing
and certification of the specific products
covered within its scope of recognition
and is not a delegation or grant of
government authority. As a result of
recognition, employers may use
products ‘‘properly certified’’ by the
NRTL to meet OSHA standards that
require testing and certification.
The Agency processes applications by
an NRTL for initial recognition or for
expansion or renewal of this recognition
following requirements in Appendix A
to 29 CFR 1910.7. This appendix
requires that the Agency publish two
notices in the Federal Register in
processing an application. In the first
notice, OSHA announces the
application and provides its preliminary
finding and, in the second notice, the
Agency provides its final decision on an
application. These notices set forth the
NRTL’s scope of recognition or
modifications of this scope.
NSF submitted an application, dated
October 8, 2003 (see Exhibit 14), to
expand its recognition to include one
additional test standard. Prior to
submitting this application, NSF
submitted another application, dated
July 31, 2003 (see exhibit 15) to include
several additional programs within its
current scope of recognition. The NRTL
Program staff performed an on-site
review (assessment) of NSF’s NRTL
facilities and in the on-site review
E:\FR\FM\28FEN1.SGM
28FEN1
]]>Agencies
[Federal Register Volume 70, Number 38 (Monday, February 28, 2005)]
[Notices]
[Pages 9677-9678]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-3800]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importation of Controlled Substances; Notice of Application
Pursuant to 21 U.S.C. 958(1), the Attorney General shall, prior to
issuing a registration under this Section to a bulk manufacturer of a
controlled substance in Schedule I or II and prior to issuing a
regulation under 21 U.S.C. 952 (a)(2)(b) authorizing the importation of
such substances, provide manufacturers holding registrations for the
bulk manufacture of the substances an opportunity for a hearing.
Therefore, in accordance with 21 CFR 1301.34(a), this is notice
that on November 11, 2004, JFC Technologies, LLC, 100 West Main Street,
PO Box 669, Bound Brook, New Jersey 08805, made application by renewal
to the Drug Enforcement Administration (DEA) for registration as an
importer of Meperidine-Intermediate B (9233), a basic class of
controlled substance listed in Schedule II.
The company plans to import the listed controlled substance for the
manufacture of controlled substances in bulk for distribution to its
customers.
Any manufacturer who is presently, or is applying to be, registered
with DEA to manufacture such basic classes of controlled substances may
file written comments or objections to the issuance of the proposed
registration and may, at the same time, file a written request for a
hearing on such application pursuant to 21 CFR 1301.43 and in such form
as prescribed by 21 CFR 1316.47.
Any such written comments or objections being sent via regular mail
may be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative, Liaison and Policy Section (ODL); or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria,
Virginia 22301; and must be filed no later than March 30, 2005.
This procedure is to be conducted simultaneously with and
independent of the procedures described in 21 CFR 1301.34(b), (c), (d),
(e), and (f). As noted in a previous notice published in the Federal
Register on September 23, 1975, (40 FR 43745-46), all applicants for
registration to import basic class of any controlled substance in
Schedule I or II are and will continue to be required to demonstrate to
the Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration that the requirements for such registration
pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1301.34(b),
(c), (d), (e), and (f) are satisfied.
[[Page 9678]]
Dated: February 17, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-3800 Filed 2-25-05; 8:45 am]
BILLING CODE 4410-09-P
